Rabies Vaccine (Pre & Post Exposure)

Rabies is almost universally fatal once symptoms appear. India accounts for ~36% of global rabies deaths (~20,000/year). Rabies vaccine can prevent the disease if given promptly after exposure (in combination with Rabies Immunoglobulin for serious exposures). Pre-exposure prophylaxis (PrEP) recommended for travelers, veterinarians, and lab workers.

The Rabies Vaccine (Pre & Post Exposure) is recommended for All ages (post-exposure); pre-exposure for high-risk groups. It falls under the Travel vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The Rabies Vaccine (Pre & Post Exposure) has an efficacy of 100% effective when administered correctly following exposure before symptoms appear. This means it provides significant protection against Rabies (100% fatal viral encephalitis caused by Rabies lyssavirus). Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Pain; swelling at injection site; mild fever; headache. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The Rabies Vaccine (Pre & Post Exposure) should be avoided by: No absolute contraindication for post-exposure (PEP) — rabies is fatal without treatment. Pre-exposure: Defer for mild illness. Allergy to neomycin; chlortetracycline; or amphotericin B.. Always inform your healthcare provider of your full medical history before vaccination.

The Rabies Vaccine (Pre & Post Exposure) typically costs ₹350–₹800 per dose (PEP typically 4 doses) in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.